Ó³»´«Ã½ core institute members Feng Zhang and David Liu, institute member and clinical geneticist Heidi Rehm, and policy advisor Bina Vekarataman host a conversation with the Ó³»´«Ã½ community about claims regarding children born from CRISPR-edited embryos, what is and is not known about the claims (and the state of the science behind them), the ethical issues they raise, and discuss where genome editing and other efforts to address unmet medical needs might go from here.